Innovative Therapies for Eye Diseases

SELAGINE, Inc. develops novel antibody-based biologic eye drops for treatment of immunological or inflammatory ocular surface diseases such as Dry Eye Disease, Sjögren’s syndrome and ocular Graft-versus-Host Disease.

SELAGINE

SELAGINE Inc, 2201 W. Campbell Park Drive, MB: 26, Chicago,  IL 60612